article · 2025
Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer
Our study identifies known and novel prognostic and predictive biomarker candidates in patients with mCRPC undergoing first-line treatment with enzalutamide ...
1 citationsDOI: https://doi.org/10.1186/s13046-025-03356-0Open accessPDF reported by metadataFull text reported by metadata